This protocol addresses the management of epilepsy with myoclonic absences specifically in pediatric patients younger than 16 years — a distinct population requiring age-appropriate therapeutic decisions.
When initial antiepileptic measures prove insufficient, management involves initiating combination therapy with indicated antiepileptic agents. The specific drug selection, sequencing, and full regimen are available in the complete protocol.